saveferris2009
New member
<div class="FTQUOTE"><begin quote><i>Originally posted by: <b>Jeana</b></i>
Okay, it appears to me by looking at other studies that 20 mL is about 1%. So, it appears that those on Denufosol had an FEV1 increase of about 6% after 48 weeks. The only thing that worries me is that if I get the placebo, since you aren't allowed to be on hypertonic that my lung function may decrease in the first year without hypertonic or Denufosol. The second year I would get to be on Denufosol for sure though...</end quote></div>
First: it depends on what you're expected FEV1 is as to how you calculate the %, which is why this study doesn't quote improvement in %. Some very tall men have high expected FEV1's, where are shorter women have smaller expected FEV1. To make it apples to apples, you quote in absolute millileter improvement, not %.
You are right about having to stop HTS... it's a concern. The other concern is that you don't know all the side effects of any VX drug - whereas you do know side effects of Denufosol from Tiger I (300+ patients).
So there are benefits and drawbacks of both.
Again I think what's really important is that you're getting involved. You have a choice between 2 great meds which is very exciting and by enrolling you're helping the entire CF population. <img src="i/expressions/face-icon-small-smile.gif" border="0">
Okay, it appears to me by looking at other studies that 20 mL is about 1%. So, it appears that those on Denufosol had an FEV1 increase of about 6% after 48 weeks. The only thing that worries me is that if I get the placebo, since you aren't allowed to be on hypertonic that my lung function may decrease in the first year without hypertonic or Denufosol. The second year I would get to be on Denufosol for sure though...</end quote></div>
First: it depends on what you're expected FEV1 is as to how you calculate the %, which is why this study doesn't quote improvement in %. Some very tall men have high expected FEV1's, where are shorter women have smaller expected FEV1. To make it apples to apples, you quote in absolute millileter improvement, not %.
You are right about having to stop HTS... it's a concern. The other concern is that you don't know all the side effects of any VX drug - whereas you do know side effects of Denufosol from Tiger I (300+ patients).
So there are benefits and drawbacks of both.
Again I think what's really important is that you're getting involved. You have a choice between 2 great meds which is very exciting and by enrolling you're helping the entire CF population. <img src="i/expressions/face-icon-small-smile.gif" border="0">